KDNY — Chinook Therapeutics Share News
0.000.00%
Last trade - 00:00- $2.90bn
- $2.60bn
- $6.13m
U.S. STOCKS ON THE MOVE-ProQR Therapeutics, IsoPlexis Corp, Tesla, AMC Entertainment
Chinook Therapeutics PT raised by Stifel on optimism over kidney disease treatment
Brief: Chinook Therapeutics Inc Files Prospectus Supplement For Potential Offering Of Up To $150 Million Of Common Stock
Chinook Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Chinook Therapeutics Inc Reports Q3 EPS Of $0.83
Chinook Therapeutics Inc expected to post a loss of 64 cents a share - Earnings Preview
Brief: Chinook Therapeutics Provides Business Update And Reports Second Quarter 2022 Financial Results
Chinook Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Chinook Therapeutics Inc expected to post a loss of 61 cents a share - Earnings Preview
Brief: Chinook Therapeutics Receives Orphan Drug Designation From European Commission For BION-1301
Refile: BUZZ-U.S. STOCKS ON THE MOVE-Intuit, Snap Inc, Moderna, Albemarle Corp
U.S. STOCKS ON THE MOVE-Chewy Inc, Nvidia Corp, Pfizer Inc
U.S. STOCKS ON THE MOVE-Apple Inc, Lyft Inc, Zhihu Inc
Chinook Therapeutics drops on $105 mln stock deal
Brief: Chinook Therapeutics Announces Pricing Of Its Underwritten Public Offering Of 6.4 Mln Common Shares At $14/Share
Brief: Chinook Therapeutics Announces Proposed Public Offering
Brief: Chinook Therapeutics Inc Files For Potential Mixed Shelf Offering Size Not Disclosed - SEC Filing
Brief: Chinook Therapeutics Says BION-1301 Remains Well-Tolerated in Phase 1/2
Chinook Therapeutics Inc reports results for the quarter ended in March - Earnings Summary